Showing results (991-1000 of 1,039) with videos related to

Sort By:
Pageof 104
Bone Marrow Transplantation|March 21, 2017
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromesR Martino, A Henseler, M van Lint, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 1, 2005
Capacity building for international tuberculosis control through operations research trainingK F Laserson, N J Binkin, L E Thorpe, et al.
British Journal of Haematology|June 8, 2017
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)Johannes Schetelig, Liesbeth C de Wreede, Niels S Andersen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2018
Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensusMaarten Lambrecht, Daniëlle B P Eekers, Claire Alapetite, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|October 14, 2000
Safety, efficacy, and durability of carotid artery stenting for restenosis following carotid endarterectomy: a multicenter studyG New, G S Roubin, S S Iyer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 9, 2019
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationDonal McLornan, Richard Szydlo, Linda Koster, et al.
The Lancet. Neurology|October 26, 2010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialWilliam J Marks, Raymond T Bartus, Joao Siffert, et al.
Haematologica|February 9, 2019
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosisMarie Robin, Liesbeth C de Wreede, Christine Wolschke, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 12, 2017
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMTMichel van Gelder, Dimitris Ziagkos, Liesbeth de Wreede, et al.
The Lancet. Neurology|January 14, 2012
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trialMichael S Okun, Bruno V Gallo, George Mandybur, et al.
Pageof 104